Over 150 point mutations in the human type-2 ryanodine receptor gene (RYR2) have been identified to associate with catecholaminergic polymorphic ventricular tachycardia (CPVT1). Here, RYR2 is linked to catecholaminergic polymorphic ventricular tachycardia 1.